Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01MAU
|
||||
| Former ID |
DIB013153
|
||||
| Drug Name |
AZD-1446
|
||||
| Synonyms |
TC-6683; Alpha-4 beta-2 neuronal nicotinic receptor modulator (oral, cognitive disorder), Targacept/AstraZeneca
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 2 | [522853] | ||
| Company |
Targacept Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H13ClN2O2
|
||||
| Canonical SMILES |
Clc1oc(cc1)C(=O)N2CC3CNCC3C2
|
||||
| InChI |
1S/C11H13ClN2O2/c12-10-2-1-9(16-10)11(15)14-5-7-3-13-4-8(7)6-14/h1-2,7-8,13H,3-6H2
|
||||
| InChIKey |
GTUIQNHJSXQMKW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Nicotinic ACh receptor alpha 4/beta 2 | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.